CLINICAL MASAOKA STAGE II TO IVA

Clinical trials for CLINICAL MASAOKA STAGE II TO IVA explained in plain language.

Never miss a new study

Get alerted when new CLINICAL MASAOKA STAGE II TO IVA trials appear

Sign up with your email to follow new studies for CLINICAL MASAOKA STAGE II TO IVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to shrink tough thymus tumors before surgeons operate

Disease control Ongoing

This study tested whether adding the drug cetuximab to standard chemotherapy could better shrink advanced thymoma or thymic carcinoma tumors before surgery. It involved 18 patients with these rare cancers that had not spread to distant organs. The goal was to see if this combinat…

Matched conditions: CLINICAL MASAOKA STAGE II TO IVA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 11, 2026 14:53 UTC

CLINICAL MASAOKA STAGE II TO IVA

Get alerted when new CLINICAL MASAOKA STAGE II TO IVA trials appear

New drug combo aims to shrink tough thymus tumors before surgeons operate